Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
267.02
+2.62 (0.99%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.18 billion as of March 27, 2026. Its market cap has increased by 4.87% in one year.
Market Cap
7.18B
Enterprise Value
7.02B
1-Year Change
4.87%
Ranking
Category
Stock Price
$267.02
Market Cap Chart
Since March 30, 2021, Bio-Rad Laboratories's market cap has decreased from $16.82B to $7.18B, a decrease of -57.33%. That is a compound annual growth rate of -15.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.16B | -12.23% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 34.42% |
| Mar 30, 2021 | 16.82B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insulet | 14.66B |
| Smith & Nephew | 13.44B |
| Penumbra | 13.15B |
| Globus Medical | 11.31B |
| Masimo | 9.51B |
| Bio-Rad Laboratories | 7.16B |
| Glaukos | 5.99B |
| Bruker | 5.13B |